Advanced Antibody Discovery.
Engineered for breakthroughs.
Reprogramming Immunity, Precisely.
Multi-specific platforms that deliver T cell co-stimulation,
tumor selectivity, and controlled payloads.
로딩 중...
Core Technologies
Innovative solutions driving the future of therapeutics
Bispecific ADC.
“Built to Wait. Wired to Strike.”
Conditionally active payloads that engage only when the environment is right.
Learn More →
T cell engager.
“Engineer the Synapse. Elevate the Response.”
Trispecific TCEs designed for precision engagement and deeper activation.
Explore the Platform →Pioneering expertise in
antibody and immunotherapy.
Cyron Therapeutics is committed to breakthrough solutions for patients, leveraging advanced antibody engineering, ADCs, and T-cell engager platforms.